Phenoxybenzamine in Complex Regional Pain Syndrome: Potential Role and Novel Mechanisms
There is a relatively long history of the use of the α-adrenergic antagonist, phenoxybenzamine, for the treatment of complex regional pain syndrome (CRPS). One form of this syndrome, CRPS I, was originally termed reflex sympathetic dystrophy (RSD) because of an apparent dysregulation of the sympathe...
Saved in:
Main Author: | Mario A. Inchiosa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Anesthesiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2013/978615 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complex regional pain syndrome with an unusual aetiology
by: Punit Pruthi, et al.
Published: (2018-01-01) -
Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS)
by: Monika Halicka, et al.
Published: (2020-01-01) -
Complex Regional Pain Syndrome in Children: Asking the Right Questions
by: Kenneth R Goldschneider
Published: (2012-01-01) -
The Prevalence of Autoantibodies in Complex Regional Pain Syndrome Type I
by: Maaike Dirckx, et al.
Published: (2015-01-01) -
Evidence for local inflammation in complex regional pain syndrome type 1
by: Frank J. P. M. Huygen, et al.
Published: (2002-01-01)